|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents | ||||||||||
| Short-term investments | ||||||||||
| Trade receivables, less allowance of $238 in 2014 | ||||||||||
| Inventory | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Total current assets | ||||||||||
| Acquired in process research and development | ||||||||||
| Intangible assets, net of amortization | ||||||||||
| Goodwill | ||||||||||
| Property and equipment, net | ||||||||||
| Restricted cash | ||||||||||
| Deferred charge, net | ||||||||||
| Deferred offering costs | ||||||||||
| Other assets | ||||||||||
| Total assets | ||||||||||
| Liabilities and Stockholders' Equity (Deficit) | ||||||||||
| Current liabilities: | ||||||||||
| Accounts payable | ||||||||||
| Accrued expenses | ||||||||||
| Current portion of long-term debt | ||||||||||
| Deferred revenue | ||||||||||
| Income taxes payable | ||||||||||
| Total current liabilities | ||||||||||
| Long-term debt | ||||||||||
| Non-current income tax payable | ||||||||||
| Contingent consideration | ||||||||||
| Contingent liability | ||||||||||
| Accrued interest liability | ||||||||||
| Other liabilities | ||||||||||
| Other liabilities | ||||||||||
| Total liabilities | ||||||||||
| Redeemable portion-Series A Convertible Preferred Stock, $0.01 par value, 6,000,000 shares issued and outstanding at December 31, 2011 (liquidation preference $6,000,000) | ||||||||||
| Stockholders' equity (deficit): | ||||||||||
| Common stock, $0.01 par value; 125,000,000 shares authorized at September 30, 2014 and December 31, 2013, respectively; 26,787,903 and 26,625,749 shares issued and outstanding at September 30, 2014 and December 31, 2013, respectively | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit during the development stage | ||||||||||
| Preferred stock, $0.01 par value; 5,000,000 shares authorized at September 30, 2014 and December 31, 2013; no shares issued and outstanding at September 30, 2014 or December 31, 2013 | ||||||||||
| Series A Convertible Preferred Stock | ||||||||||
| Total preferred stock, $0.01 par value; 5,000,000 shares authorized at September 30, 2014 and December 31, 2013; no shares issued and outstanding at September 30, 2014 or December 31, 2013 | ||||||||||
| Accumulated deficit | ||||||||||
| Total stockholders' equity (deficit) | ||||||||||
| Total liabilities and stockholders' equity (deficit) |
Loading...
